541.52
1.05%
-5.73
Pre-market:
540.00
-1.52
-0.28%
Overview
News
Price History
Option Chain
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc. stock is currently priced at $541.52, with a 24-hour trading volume of 2.06M.
It has seen a -1.05% decreased in the last 24 hours and a -6.64% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $549.9 pivot point. If it approaches the $540.4 support level, significant changes may occur.
Thermo Fisher Scientific Inc. Stock (TMO) Financials Data
Thermo Fisher Scientific Inc. (TMO) Revenue 2024
TMO reported a revenue (TTM) of $42.86 billion for the quarter ending December 31, 2023, a -4.58% decline year-over-year.
Thermo Fisher Scientific Inc. (TMO) Net Income 2024
TMO net income (TTM) was $6.00 billion for the quarter ending December 31, 2023, a -13.74% decrease year-over-year.
Thermo Fisher Scientific Inc. (TMO) Cash Flow 2024
TMO recorded a free cash flow (TTM) of $6.93 billion for the quarter ending December 31, 2023, a +0.23% increase year-over-year.
Thermo Fisher Scientific Inc. (TMO) Earnings per Share 2024
TMO earnings per share (TTM) was $15.45 for the quarter ending December 31, 2023, a -12.37% decline year-over-year.
Thermo Fisher Scientific Inc. Stock (TMO) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
CASPER MARC N | Chairman & CEO |
Mar 13 '24 |
Option Exercise |
190.59 |
10,000 |
1,905,900 |
133,816 |
CASPER MARC N | Chairman & CEO |
Mar 13 '24 |
Sale |
594.58 |
10,000 |
5,945,759 |
123,816 |
Britt Lisa P. | Sr. VP and Chief HR Officer |
Mar 12 '24 |
Option Exercise |
198.85 |
14,345 |
2,852,545 |
25,768 |
CASPER MARC N | Chairman & CEO |
Mar 12 '24 |
Option Exercise |
190.59 |
10,000 |
1,905,900 |
133,816 |
Britt Lisa P. | Sr. VP and Chief HR Officer |
Mar 12 '24 |
Sale |
598.90 |
14,345 |
8,591,220 |
17,323 |
CASPER MARC N | Chairman & CEO |
Mar 12 '24 |
Sale |
597.98 |
10,000 |
5,979,758 |
123,816 |
CASPER MARC N | Chairman & CEO |
Mar 11 '24 |
Option Exercise |
190.59 |
10,000 |
1,905,900 |
135,816 |
CASPER MARC N | Chairman & CEO |
Mar 11 '24 |
Sale |
595.36 |
10,000 |
5,953,598 |
125,816 |
CASPER MARC N | Chairman & CEO |
Feb 29 '24 |
Option Exercise |
190.59 |
10,000 |
1,905,900 |
135,816 |
CASPER MARC N | Chairman & CEO |
Feb 29 '24 |
Sale |
571.08 |
10,000 |
5,710,818 |
125,816 |
Thermo Fisher Scientific Inc. Stock (TMO) Latest News
TMO vs. IDXX: Which Stock Is the Better Value Option?
Zacks Investment Research
What's in Store for Thermo Fisher (TMO) in Q1 Earnings?
Zacks Investment Research
Labcorp's (LH) At-Home Mpox Testing Kit Gets the FDA's EUA Nod
Zacks Investment Research
Waters (WAT) Boosts Waters Operating Segment With HPLC System
Zacks Investment Research
Charles River (CRL) Forges Collaboration With Ship of Theseus
Zacks Investment Research
Thermo Fisher (TMO) Launches TSX Universal Series ULT Freezers
Zacks Investment Research
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
Cap:
|
Volume (24h):